Table 4.
Postoperative complications attributed to implant material.
| Implant Material | Total Number of Patients | Complications Rates (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Exposure/Extrusion | Fistula | Infection | Inflammation | Pain | Persistent/Prolonged Oedema | Prominence | Removal of Implant | Overall | ||
| Autologous Calvarial Bone | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Autologous Iliac Bone | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Autologous Bone (unspecified donor site) | 71 | 0 | 0 | 5.6 | 0 | 0 | 0 | 0 | 5.6 | 11.3 |
| Autologous Conchal Ear Cartilage | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Autologous Nasal Septal Cartilage | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Allogenic Lyophilized Dura | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Titanium | 741 | 0 | 0 | 1.1 | 0 | 0 | 0 | 0 | 1.3 | 2.4 |
| Porous Polyethylene | 326 | 0.7 | 0 | 2.3 | 0 | 0 | 0 | 0 | 2.3 | 5.4 |
| Dense Polyethylene | 78 | 0 | 0 | 2.6 | 0 | 0 | 3.8 | 0 | 1.3 | 7.7 |
| Bioactive Glass | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.0 | 2.0 |
| Silicone | 530 | 3.0 | 0 | 4.7 | 0 | 1.1 | 0.4 | 0.4 | 7.9 | 17.5 |
| Teflon (PTFE) | 702 | 0.6 | 0.1 | 0.4 | 0 | 0 | 0 | 0 | 1.3 | 2.4 |
| Polyglycolic Acid (PGA) | 78 | 0 | 0 | 0 | 1.3 | 0 | 0 | 0 | 0 | 1.3 |
| Polyglactin | 28 | 0 | 0 | 0 | 14.3 | 0 | 0 | 0 | 0 | 14.3 |
| Polydioxanone | 774 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.1 |
| Poly-D-Lactic Acid | 176 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unspecified Implants | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |